Kaye AD, Sala KR, Abbott BM, Dicke AN, Johnson LD, Wilson PA, Amarasinghe SN, Singh N, Ahmadzadeh S, Kaye AM, Shekoohi S, Varrassi G (2024) The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review
This variability could have impacted the consistency of the results and the overall interpretation of gastrointestinal adverse events
Ouellet-Morin, I
Furthermore, L-carnitine works exceptionally well when paired with other mitochondrial targeted therapies
When the skin is overwhelmed by these rays, it produces excess melanin to protect itself, leading to darker patches and a lack of radiance
The lower end of the dose range is cited for body-size and baseline GH-response reasons